2013 Women & HIV


Web-Based Recorded Sessions.
Empowering clinicians to provide timely care to women living with or at risk of contracting HIV.


The TX/OK AIDS Education & Training Center (TX/OK AETC) is proud to announce the 2013 "Women & HIV Web-Based Recorded Sessions." These modules were created from a two-day face-to-face conference entitled, "Women & HIV International Clinical Conference (WHICC)" which was hosted at the Magnolia Hotel May 3-4, 2013 in Dallas, Texas. The goal of these self-study modules is to “Empower clinicians to provide timely care to women living with or at risk of contracting HIV”.



HIV disproportionally affects women, especially those who live in poverty and under unstable housing conditions.

  • 25% of adults and adolescents aged 13 years or older living with a diagnosis of HIV in the United States are women (1)
  • In 2011, an estimated 10,257 women aged 13 years or older were diagnosed HIV positive (2)
  • Women accounted for 25% (7,949) of the estimated 32,052 AIDS diagnoses in 2011 (2)
  • In 2010, an estimated 217 children younger than the age of 13 years were diagnosed with HIV and 162 (75%) of those children were prenatally infected (1)
  • From the beginning of the epidemic through 2009, an estimated 5,626 people who were diagnosed with AIDS were younger than 13 years died in the 50 stated and District of Colombia. Of the total 4,986 (89%) of them were infected perinatally (1)

According to UNAIDS, violence against women is both a cause and a consequence of HIV/AIDS. The Office on Women’s’ Health also notes that women living with HIV may be at risk of violence when disclosing their HIV status to their partner.

The Texas/Oklahoma AIDS Education & Training Center (TX/OK AETC) in conjunction with other State and National agencies are working hard to provide health care providers treating women living with or at risk of contracting HIV with up to date medical updates. This modules will provide health care providers with information and tools to provide timely care to women living with or at risk of contracting HIV.

_ _ _ _ _

Overall Learning Objectives

At the end of each session, participants will be able to:

  1. Identify two ways to properly assess women living with HIV for Intimate Partner Violence.
  2. State two prevention methods for sero-discordant couples to reduce the risk of HIV transmission.
  3. Discuss two strategies to assess and manage HIV risk in female adults.
  4. Describe two current treatment regimens to reduce the risk of perinatal HIV transmission.
  5. Review the epidemiologic trends of HIV infected women in the U.S. and internationally.
  6. Identify two current treatment options for HIV-positive women.



  • Step 1: Review details on each session such as speakers, topics, brief descriptions, disclosures, & learning objectives in the section entitled, "Session Details" at the bottom of this page. You may participate in as many sessions as desired.
  • Step 2: To access each session desired, click-on the corresponding button below in the section entitled, "Registration". Sessions will be taken one-at-a-time. When you are done with one session, you will be routed back to this page to take another..
  • Step 3: After you have viewed the session, you will be routed to complete a post-test. To successfully complete the session, you must pass the post-test with a score of 70% or better.
  • Step 4: Once you pass the post-test, you will be required to complete a short evaluation on the session.
  • Step 5: Once the evaluation has been completed, you will be asked if you would like to request CEs. If you are interested, you will be routed to complete a "CE Request Form." If you say no, you will be routed to Step 7 below.
  • Step 6: You will be routed back to this webpage to complete another session!



These faculty members do not have any relevant financial relationships to disclose.




Laura Armas-Kolostroubis, MD, AAHIVS

Associate Professor, Co-Medical Director

UF Center for HIV/AIDS, Research, Education & Service

Melanie M. Taylor, MD, MPH

Medical Epidemiologist in the Division of STD Prevention

National center for HIV, Hepatitis, STD & TB Prevention of the Centers for Disease Control & Prevention

Jeanne Sheffield, MD

Director - Maternal-Fetal Medicine Fellow Program

University of Texas Southwestern Medical Center

Katia V. Brown, MD

Infectious Disease Provider, Assistant Professor

University of Texas Southwestern Medical Center

Gina Brown, MD

Coordinator, Microbicides & Women & Girls HIV Research

Office of AIDS Research, NIH

Deborah Phillips, BSN, RN, MPH

Associate Director

TX/OK AIDS Education & Training Center

Kimberly Bickes, RN, MS, ACRN

Nurse Clinician

Phoenix Children's Hospital, Bill Holt Clinic

Ellen J. Elliston, PhD, LCSW, CDVC

Director, Victim Intervention Program/Rape Crisis

Parkland Health & Hospital System (Retired in 2013)

Anne Donnelly, MA

Health Care Policy Director

Project Inform

Dr. Short has disclosed speaker/consultant relationship with Gilead Sciences and Janssen Pharmaceuticals, He has received honoraria.




William Short, MD, MPH, AAHIVS

Assistant Professor of Medicine

Jefferson Medical College, Thomas Jefferson University

Target Audience:

Clergy/Faith-Based Professional , Dietitian/Nutritionist , Dentist , Health Educator , Mental Health Professional , Nurse , Nurse practitioner , Public Health Professional , Professional , Other Advanced Practice Nurse , Pharmacist , Physician , Physician Assistant , Social Worker , Substance Abuse Professional

 CE Accreditation


Women , Women & HIV

Seminars: Details & Registrations